Trial Profile
Safety of high-dose micafungin for patients with hematological diseases.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Micafungin (Primary)
- Indications Haematological disorders
- Focus Adverse reactions
- 04 Dec 2015 New trial record